The Ensign Group, Inc. (ENSG) Hisse Analizi
Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
202.49$'dan işlem gören The Ensign Group, Inc. (ENSG), $11.77B değerindeki bir Healthcare şirketidir. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 49/100 (ihtiyatlı) olarak derecelendirilmiştir.
Son analiz: 8 Şub 2026The Ensign Group, Inc. (ENSG) Sağlık ve Boru Hattı Genel Bakışı
The Ensign Group, Inc. (ENSG) delivers comprehensive post-acute healthcare services, leveraging its skilled services and real estate segments to provide integrated care solutions across 252 facilities in 14 states, driving growth and shareholder value with a 6.8% profit margin.
Yatırım Tezi
The Ensign Group presents a notable research candidate within the growing post-acute care sector. With a market capitalization of $11.49 billion and a P/E ratio of 33.11, Ensign demonstrates financial stability and growth potential. The company's 6.8% profit margin and 13.7% gross margin indicate efficient operations. Key value drivers include the increasing demand for skilled nursing and rehabilitative services due to the aging population and the rising prevalence of chronic diseases. Growth catalysts include strategic acquisitions of underperforming facilities, operational improvements to enhance profitability, and expansion of ancillary services. Investing in Ensign offers exposure to a well-managed healthcare provider with a proven track record of growth and a commitment to delivering high-quality patient care. The company's dividend yield of 0.13% provides a modest income stream, while its beta of 0.87 suggests lower volatility compared to the broader market.
FMP finansallarına ve nicel analizine dayanmaktadır
Temel Önemli Noktalar
- Market capitalization of $11.49 billion reflects strong investor confidence in Ensign's market position and growth prospects.
- P/E ratio of 33.11 indicates a premium valuation, reflecting expectations of future earnings growth.
- Profit margin of 6.8% demonstrates efficient cost management and profitability in the competitive healthcare services market.
- Gross margin of 13.7% highlights the company's ability to generate revenue exceeding the direct costs of providing services.
- Operation of 252 healthcare facilities across 14 states provides a diversified revenue base and geographic reach.
Rakipler & Benzerleri
Güçlü Yönler
- Diversified service offerings across the post-acute care continuum.
- Established presence in multiple states with a large network of facilities.
- Proven ability to acquire and improve underperforming assets.
- Strong relationships with referral sources and payers.
Zayıflıklar
- Exposure to regulatory changes and reimbursement pressures.
- Dependence on government funding sources (Medicare and Medicaid).
- Labor-intensive business model with high staffing costs.
- Potential for liability claims related to patient care.
Katalizörler
- Upcoming: Continued strategic acquisitions of underperforming facilities to expand market presence.
- Ongoing: Expansion of ancillary services to drive revenue growth and improve patient outcomes.
- Ongoing: Implementation of operational efficiencies to reduce costs and improve profitability.
- Upcoming: Development of new senior living communities to capitalize on growing demand.
- Ongoing: Leveraging technology to enhance patient care and improve operational efficiency.
Riskler
- Potential: Changes in government regulations and reimbursement policies could negatively impact revenue.
- Potential: Increased competition from other post-acute care providers could erode market share.
- Ongoing: Rising labor costs and staffing shortages could pressure profitability.
- Potential: Economic downturn could affect patient volumes and payer mix.
- Ongoing: Potential for liability claims related to patient care.
Büyüme Fırsatları
- Expansion of Ancillary Services: Ensign can drive revenue growth by expanding its ancillary services, such as mobile diagnostics (digital x-ray, ultrasound, electrocardiogram), laboratory services, and patient transportation. The market for mobile diagnostics is projected to reach $36.8 billion by 2028, offering a significant opportunity for Ensign to capture additional market share. Timeline: Ongoing.
- Strategic Acquisitions: Ensign has a proven track record of acquiring and improving underperforming healthcare facilities. By continuing to identify and acquire such facilities in strategic markets, Ensign can expand its geographic footprint and increase its patient base. The market for healthcare acquisitions remains active, providing ample opportunities for Ensign to grow through inorganic means. Timeline: Ongoing.
- Enhanced Operational Efficiency: By implementing best practices in operational management, Ensign can improve the efficiency and profitability of its existing facilities. This includes optimizing staffing levels, reducing costs, and improving patient outcomes. The potential for cost savings through operational improvements is substantial, contributing to increased profitability. Timeline: Ongoing.
- Development of Senior Living Communities: Ensign can capitalize on the growing demand for senior living options by developing and managing its own senior living communities. This would provide a complementary revenue stream and further integrate its services within the post-acute care continuum. The senior living market is projected to reach $120 billion by 2027, presenting a significant growth opportunity. Timeline: Upcoming.
- Leveraging Technology: Implementing advanced technologies, such as telehealth and remote patient monitoring, can improve patient care, reduce costs, and enhance operational efficiency. The market for telehealth is projected to reach $55 billion by 2027, offering opportunities for Ensign to integrate technology into its service delivery model. Timeline: Ongoing.
Fırsatlar
- Expansion into new geographic markets.
- Development of new service lines, such as telehealth and home health.
- Increased demand for senior living and long-term care services.
- Strategic partnerships with hospitals and healthcare systems.
Tehditler
- Increased competition from other post-acute care providers.
- Changes in government regulations and reimbursement policies.
- Rising labor costs and staffing shortages.
- Economic downturn affecting patient volumes and payer mix.
Rekabet Avantajları
- Established network of 252 healthcare facilities across 14 states.
- Integrated service offerings across the post-acute care continuum.
- Strong relationships with referral sources, including hospitals and physicians.
- Proven track record of acquiring and improving underperforming facilities.
ENSG Hakkında
The Ensign Group, Inc., founded in 1999 and headquartered in San Juan Capistrano, California, is a leading provider of healthcare services within the post-acute care continuum. The company operates through two primary segments: Skilled Services and Real Estate. The Skilled Services segment offers a wide range of services, including short and long-term nursing care for individuals with chronic conditions, prolonged illnesses, and the elderly. These services are complemented by physical, occupational, and speech therapies, along with other rehabilitative and healthcare services. Ensign also provides standard services such as room and board, specialized nutritional programs, and social and recreational activities. The Real Estate segment focuses on leasing real estate properties, supporting the operational needs of the skilled services facilities. Additionally, Ensign offers senior living options and mobile diagnostic services, including digital x-ray, ultrasound, and electrocardiogram services. The company extends its ancillary services to include laboratory, sub-acute, and patient transportation services, catering to individuals in their homes or at long-term care facilities. As of April 4, 2022, Ensign operated 252 healthcare facilities across 14 states, including Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. Ensign's integrated approach and diverse service offerings position it as a key player in the expanding post-acute care market.
Ne Yaparlar
- Provides short and long-term nursing care services.
- Offers physical, occupational, and speech therapies.
- Delivers rehabilitative and healthcare services.
- Provides room and board and specialized nutritional programs.
- Offers social, recreational, and entertainment activities.
- Provides senior living options.
- Offers mobile diagnostics services (x-ray, ultrasound, EKG).
- Leases real estate properties to healthcare facilities.
İş Modeli
- Generates revenue from providing skilled nursing and rehabilitative services to patients.
- Earns income from leasing real estate properties to healthcare operators.
- Receives payments from Medicare, Medicaid, private insurance, and self-pay patients.
- Expands service offerings to include ancillary services like mobile diagnostics and patient transportation.
Sektör Bağlamı
The Ensign Group operates in the medical care facilities industry, which is experiencing growth driven by an aging population and increasing demand for post-acute care services. The market is competitive, with key players including DaVita (DVA), Encompass Health Corporation (EHC), and other regional and national providers. The industry is also subject to regulatory changes and reimbursement pressures, requiring companies to adapt and innovate to maintain profitability. Ensign's focus on operational efficiency, strategic acquisitions, and expansion of ancillary services positions it favorably within this dynamic landscape. The increasing prevalence of chronic diseases and the growing need for rehabilitative care further contribute to the industry's growth prospects.
Kilit Müşteriler
- Individuals requiring short-term rehabilitation after surgery or illness.
- Elderly individuals needing long-term nursing care.
- Patients with chronic conditions requiring ongoing medical support.
- Hospitals and healthcare systems seeking post-acute care partners.
Finansallar
Grafik & Bilgi
The Ensign Group, Inc. (ENSG) hisse senedi fiyatı: $202.49 (+0.00, +0.00%)
Son Haberler
-
Dow Jones Breaks As Oil Prices, Yields Soar, But Then Trump Mulls 'Winding Down' Iran War
Investor's Business Daily · 20 Mar 2026
-
Nova Stock Up 80% in a Year, so What Should Investors Know About This $194 Million Sale?
Yahoo! Finance: ENSG News · 24 Şub 2026
-
Trex Stock Down 36% as Wasatch Sells Off $63 Million in Shares
Yahoo! Finance: ENSG News · 24 Şub 2026
-
Valvoline Adds 200 Stores, Grows Sales 11%, but One Fund Still Sold Off $67 Million in Stock
Yahoo! Finance: ENSG News · 24 Şub 2026
Analist Konsensüsü
Fikir Birliği Derecelendirmesi
ENSG için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.
Fiyat Hedefleri
Konsensüs hedefi: $220.40
MoonshotScore
Bu puan ne anlama geliyor?
MoonshotScore, ENSG'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.
Rakipler & Benzerleri
Son Haberler
Dow Jones Breaks As Oil Prices, Yields Soar, But Then Trump Mulls 'Winding Down' Iran War
Nova Stock Up 80% in a Year, so What Should Investors Know About This $194 Million Sale?
Trex Stock Down 36% as Wasatch Sells Off $63 Million in Shares
Valvoline Adds 200 Stores, Grows Sales 11%, but One Fund Still Sold Off $67 Million in Stock
En Son The Ensign Group, Inc. Analizi
The Ensign Group, Inc. Hissesi: Cevaplanan Temel Sorular
ENSG için değerlendirilmesi gereken temel faktörler nelerdir?
The Ensign Group, Inc. (ENSG) şu anda yapay zeka skoru 49/100, düşük puanı gösteriyor. Hisse 35.8x F/K oranıyla işlem görüyor, S&P 500 ortalamasının (~20-25x) üzerinde, yüksek büyüme beklentilerine işaret ediyor. Analist hedefi $220.40 ($202.49'dan +9%). Temel güçlü yan: Diversified service offerings across the post-acute care continuum.. İzlenmesi gereken birincil risk: Potential: Changes in government regulations and reimbursement policies could negatively impact revenue.. Bu bir finansal tavsiye değildir.
ENSG MoonshotScore'u nedir?
ENSG şu anda MoonshotScore'da 49/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.
ENSG verileri ne sıklıkla güncellenir?
ENSG fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.
Analistler ENSG hakkında ne diyor?
Analistler, ENSG için $220.40 konsensüs fiyat hedefi belirledi, bu mevcut fiyattan ($202.49) yukarı yönlü %9 potansiyeli temsil ediyor. Kapsam, al, tut ve sat derecelendirmelerini, kazanç tahminlerini ve son yükseltmeleri veya düşürmeleri içerir. Tüm ayrıntılar için bu sayfadaki Analist Konsensüsü bölümüne bakın.
ENSG'a yatırım yapmanın riskleri nelerdir?
ENSG için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Changes in government regulations and reimbursement policies could negatively impact revenue.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.
ENSG'ın P/E oranı nedir?
The Ensign Group, Inc. (ENSG)'nın son P/E oranı 35.8, ki bu da piyasa ortalamasının üzerinde, bu da yüksek büyüme beklentilerini gösterebilir. P/E (fiyat-kazanç) oranı, hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Bağlam için bunu sektördeki emsallerle ve S&P 500 ortalamasıyla (~20-25x) karşılaştırın. Yüksek bir P/E beklenen gelecekteki büyümeyi yansıtabilirken, düşük bir P/E değer düşüklüğünü veya azalan kazançları gösterebilir. Bu bir finansal tavsiye değildir.
ENSG aşırı değerli mi, yoksa düşük değerli mi?
The Ensign Group, Inc. (ENSG)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. P/E oranı 35.8. Analist hedefi $220.40 (mevcut fiyattan +9%), analistlerin hisse senedini adil değere yakın gördüğünü gösteriyor. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.
ENSG'ın temettü verimi nedir?
The Ensign Group, Inc. (ENSG) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.
Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.
Resmi Kaynaklar
Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.
- Financial data is based on available information and may be subject to change.
- Future performance is subject to market conditions and company-specific factors.